يعرض 41 - 59 نتائج من 59 نتيجة بحث عن '(( primary data relating optimization algorithm ) OR ( binary a codon optimization algorithm ))', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45

    Supplementary file 1_A study on a real-world data-based VTE risk prediction model for lymphoma patients.docx حسب Changli He (22424818)

    منشور في 2025
    "…</p>Results<p>Combining different imputation, sampling, and feature selection strategies yielded 27 datasets, which were trained across nine algorithms to generate 243 models. The optimal model—Simp-SMOTE_rf_GBM, constructed using random forest imputation, SMOTE oversampling, and gradient boosting machine—achieved the highest predictive performance (AUC = 0.954). …"
  6. 46
  7. 47
  8. 48

    Table_1_Prediction of pCR based on clinical-radiomic model in patients with locally advanced ESCC treated with neoadjuvant immunotherapy plus chemoradiotherapy.docx حسب Xiaohan Wang (691917)

    منشور في 2024
    "…Concurrently, related clinical data was amassed. Feature selection was facilitated using the Extreme Gradient Boosting (XGBoost) algorithm, with model validation conducted via fivefold cross-validation. …"
  9. 49

    CSPP instance حسب peixiang wang (19499344)

    منشور في 2025
    "…</b></p><p dir="ltr">Its primary function is to create structured datasets that simulate container terminal operations, which can then be used for developing, testing, and benchmarking optimization algorithms (e.g., for yard stacking strategies, vessel stowage planning).…"
  10. 50

    Supplementary Material for: The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics حسب Wong M.G. (11640685)

    منشور في 2021
    "…<b><i>Conclusions:</i></b> The TESTING study (combined full and low dose) will define the benefits of corticosteroid use on major kidney outcomes, as well as the risks of therapy, and provide data on the relative effects of different doses, in individuals with high-risk IgAN.…"
  11. 51

    Image 1_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.tif حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  12. 52

    Table 2_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.docx حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  13. 53

    Table 5_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.docx حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  14. 54

    Table 3_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.docx حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  15. 55

    Table 1_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.doc حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  16. 56

    Table 4_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.docx حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  17. 57

    Table 6_A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.docx حسب Dongdong Zhang (644246)

    منشور في 2024
    "…Disproportionality analysis was performed using robust algorithms for effective data mining to quantify the signals associated with Sorafenib-related AEs.…"
  18. 58

    Supplementary file 1_A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab.docx حسب Linlin Yan (4480570)

    منشور في 2025
    "…Using the Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multi-item Gamma Poisson Shrinker (MGPS) algorithms, we conducted a comprehensive analysis of lecanemab-related AEs, restricting the analysis to AEs with the role code of primary suspect (PS).…"
  19. 59

    Machine Learning-Ready Dataset for Cytotoxicity Prediction of Metal Oxide Nanoparticles حسب Soham Savarkar (21811825)

    منشور في 2025
    "…</p><p dir="ltr"><b>Applications and Model Compatibility:</b></p><p dir="ltr">The dataset is optimized for use in supervised learning workflows and has been tested with algorithms such as:</p><p dir="ltr">Gradient Boosting Machines (GBM),</p><p dir="ltr">Support Vector Machines (SVM-RBF),</p><p dir="ltr">Random Forests, and</p><p dir="ltr">Principal Component Analysis (PCA) for feature reduction.…"